1248230

AstraZeneca AB — FEI 3003342394

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 1, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sodertalje (Sweden)

Additional Details

Mutual Recognition Agreement (MRA)